RAS (KRAS OR NRAS) GENE MUTATION
Clinical trials for RAS (KRAS OR NRAS) GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new RAS (KRAS OR NRAS) GENE MUTATION trials appear
Sign up with your email to follow new studies for RAS (KRAS OR NRAS) GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets Cancer's 'MAPK Pathway' in patients out of options
Disease control Recruiting nowThis is a first-in-human study testing a new oral drug called NST-628 in adults with advanced solid tumors that have specific genetic changes. The main goals are to find a safe dose and see how the body processes the drug. The trial is for patients whose cancer has continued to g…
Matched conditions: RAS (KRAS OR NRAS) GENE MUTATION
Phase: PHASE1 • Sponsor: Nested Therapeutics, Inc • Aim: Disease control
Last updated Apr 03, 2026 22:56 UTC
-
Massive 5,500-Patient hunt for clues in rare cancer genes
Knowledge-focused Recruiting nowThis study aims to collect real-world information from 5,500 Canadian cancer patients whose tumors have rare genetic changes. Researchers will track how these patients fare with different treatments, their quality of life, and the costs of care. The goal is to better understand t…
Matched conditions: RAS (KRAS OR NRAS) GENE MUTATION
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC